Efficient transfer of antibiotic resistance plasmids by transduction within methicillin-resistant Staphylococcus aureus USA300 clone

FEMS Microbiology Letters
Marian VargaJirí Doskar

Abstract

The epidemic community-associated methicillin-resistant clone Staphylococcus aureus USA300 is a major source of skin and soft tissue infections and involves strains with a diverse set of resistance genes. In this study, we report efficient transduction of penicillinase and tetracycline resistance plasmids by bacteriophages φ80α and φJB between clinical isolates belonging to the USA300 clone. High transduction frequencies (10(-5) - 10(-6) CFU/PFU) were observed using phages propagated on donor strains as well as prophages induced from donors by ultraviolet light. Quantitative real-time PCR was employed to detect penicillinase plasmids in transducing phage particles and determine the ratio of transducing particles in phage lysates to infectious phage particles (determined as approximately 1 : 1700). Successful transfer of plasmids between strains in USA300 clone proves transduction is an effective mechanism for spreading plasmids within the clone. Such events contribute to its evolution and to emergence of new multiple drug-resistant strains of this successful clone.

References

Sep 1, 1972·Canadian Journal of Microbiology·Y Duval-Iflah
Sep 1, 1973·Antimicrobial Agents and Chemotherapy·F H KayserP Corrodi
Dec 1, 1969·Journal of General Microbiology·E H Asheshov
Oct 19, 1999·Journal of Clinical Microbiology·B ShopsinB N Kreiswirth
Aug 22, 2001·Molecular and Cellular Probes·L K NgM Mulvey
Sep 27, 2005·Journal of Microbiological Methods·Chai Lian LeeSteve Kah Weng Oh
Nov 1, 1962·Journal of Bacteriology·C E Dowell, E D Rosenblum
Nov 3, 2006·Molecular Microbiology·Taeok BaeOlaf Schneewind
Aug 2, 2007·Biological & Pharmaceutical Bulletin·Hidemasa NakaminamiMasanori Sasatsu
Jan 25, 2008·Proceedings of the National Academy of Sciences of the United States of America·Adam D KennedyFrank R DeLeo
Jan 3, 2009·Science·John Chen, Richard P Novick
Mar 19, 2009·Proceedings of the National Academy of Sciences of the United States of America·Min LiMichael Otto
Mar 31, 2009·Journal of Bacteriology·Christiane GoerkeChristiane Wolz
Jul 18, 2009·The Journal of Antimicrobial Chemotherapy·Fred C Tenover, Richard V Goering

❮ Previous
Next ❯

Citations

Dec 21, 2012·Animal Health Research Reviews·M Ellin DoyleAmy C Lee Wong
Jul 3, 2013·International Journal of Environmental Research and Public Health·Claire VerraesLieve Herman
Mar 1, 2016·Frontiers in Microbiology·Christian J H von WintersdorffPetra F G Wolffs
May 10, 2015·The Journal of Antimicrobial Chemotherapy·Kinga I Stanczak-MrozekJodi A Lindsay
Jun 22, 2014·International Journal of Medical Microbiology : IJMM·Monika A ChlebowiczGirbe Buist
May 31, 2016·Analytical Biochemistry·Monika ZovčákováBohuslav Rittich
Jun 2, 2016·Microbial Ecology·Anthony M Cundell
Oct 5, 2016·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·Allison J LopatkinLingchong You
Oct 30, 2013·Antimicrobial Agents and Chemotherapy·Pablo QuirósMaite Muniesa
Jul 6, 2019·PLoS Pathogens·Alfred Fillol-SalomJakob Haaber
Dec 4, 2016·Virology Journal·Leonardo Joaquim van ZylMarla Trindade
May 31, 2018·Viruses·Andrzej GórskiJacques Scheres
Aug 18, 2018·Scientific Reports·Leonardo Joaquim van ZylMarla Trindade
Oct 12, 2018·Emerging Microbes & Infections·Clara Torres-Barceló
Nov 30, 2019·Critical Reviews in Microbiology·Juliet Roshini Mohan Raj, Indrani Karunasagar
Nov 22, 2019·European Journal of Pharmacology·Ewa FelisEwa Korzeniewska
Jun 3, 2021·Current Microbiology·Anup Kumar OjhaVijendra Mishra
Jun 3, 2021·International Journal of Environmental Research and Public Health·Milva Pepi, Silvano Focardi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.

Bacteriophage: Phage Therapy

Phage therapy uses bacterial viruses (bacteriophages) to treat bacterial infections and is widely being recognized as an alternative to antibiotics. Here is the latest research.